IRONWOOD PHARMACEUTICALS, INC. (IRWD) Free cash flow 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$127.0MFY2025 · since FY2016: -$30.1M → $127.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $127.0M | +22.8% |
| FY2024 | $103.4M | -43.5% |
| FY2023 | $183.2M | -33.1% |
| FY2022 | $273.6M | +4.6% |
| FY2021 | $261.6M | +56.7% |
| FY2020 | $167.0M | +4622.7% |
| FY2019 | $3.5M | +105.0% |
| FY2018 | -$71.2M | +31.2% |
| FY2017 | -$103.6M | -243.6% |
| FY2016 | -$30.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice